
Digital biology is the study of the fundamental computation performed by biological processes, from gene regulatory systems to ecosystems and from neural networks to swarming systems.Ìý
The global market for Digital Biology was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Digital Biology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Digital Biology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Digital Biology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Digital Biology include DUNA Bioinformatics, Precigen (Intrexon Corporation), Dassault Systèmes, Genedata AG and Simulations Plus, Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Digital Biology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Digital Biology by region & country, by Type, and by Application.
The Digital Biology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Biology.
Market Segmentation
By Company
DUNA Bioinformatics
Precigen (Intrexon Corporation)
Dassault Systèmes
Genedata AG
Simulations Plus, Inc.
Segment by Type:
Cellular & Biological Simulation
Drug Discovery & Disease Modelling
Preclinical Drug Development
Clinical Trials
Human Body Simulation Software
Segment by Application
In-house
Contract
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Digital Biology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Digital Biology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Digital Biology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Digital Biology Product Introduction
1.2 Global Digital Biology Market Size Forecast
1.3 Digital Biology Market Trends & Drivers
1.3.1 Digital Biology Industry Trends
1.3.2 Digital Biology Market Drivers & Opportunity
1.3.3 Digital Biology Market Challenges
1.3.4 Digital Biology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Digital Biology Players Revenue Ranking (2023)
2.2 Global Digital Biology Revenue by Company (2019-2024)
2.3 Key Companies Digital Biology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Digital Biology Product Offered
2.5 Key Companies Time to Begin Mass Production of Digital Biology
2.6 Digital Biology Market Competitive Analysis
2.6.1 Digital Biology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Digital Biology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Biology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cellular & Biological Simulation
3.1.2 Drug Discovery & Disease Modelling
3.1.3 Preclinical Drug Development
3.1.4 Clinical Trials
3.1.5 Human Body Simulation Software
3.2 Global Digital Biology Sales Value by Type
3.2.1 Global Digital Biology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Digital Biology Sales Value, by Type (2019-2030)
3.2.3 Global Digital Biology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 In-house
4.1.2 Contract
4.2 Global Digital Biology Sales Value by Application
4.2.1 Global Digital Biology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Digital Biology Sales Value, by Application (2019-2030)
4.2.3 Global Digital Biology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Digital Biology Sales Value by Region
5.1.1 Global Digital Biology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Digital Biology Sales Value by Region (2019-2024)
5.1.3 Global Digital Biology Sales Value by Region (2025-2030)
5.1.4 Global Digital Biology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Digital Biology Sales Value, 2019-2030
5.2.2 North America Digital Biology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Digital Biology Sales Value, 2019-2030
5.3.2 Europe Digital Biology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Digital Biology Sales Value, 2019-2030
5.4.2 Asia Pacific Digital Biology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Digital Biology Sales Value, 2019-2030
5.5.2 South America Digital Biology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Digital Biology Sales Value, 2019-2030
5.6.2 Middle East & Africa Digital Biology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Digital Biology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Digital Biology Sales Value
6.3 United States
6.3.1 United States Digital Biology Sales Value, 2019-2030
6.3.2 United States Digital Biology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Digital Biology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Digital Biology Sales Value, 2019-2030
6.4.2 Europe Digital Biology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Digital Biology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Digital Biology Sales Value, 2019-2030
6.5.2 China Digital Biology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Digital Biology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Digital Biology Sales Value, 2019-2030
6.6.2 Japan Digital Biology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Digital Biology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Digital Biology Sales Value, 2019-2030
6.7.2 South Korea Digital Biology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Digital Biology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Digital Biology Sales Value, 2019-2030
6.8.2 Southeast Asia Digital Biology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Digital Biology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Digital Biology Sales Value, 2019-2030
6.9.2 India Digital Biology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Digital Biology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 DUNA Bioinformatics
7.1.1 DUNA Bioinformatics Profile
7.1.2 DUNA Bioinformatics Main Business
7.1.3 DUNA Bioinformatics Digital Biology Products, Services and Solutions
7.1.4 DUNA Bioinformatics Digital Biology Revenue (US$ Million) & (2019-2024)
7.1.5 DUNA Bioinformatics Recent Developments
7.2 Precigen (Intrexon Corporation)
7.2.1 Precigen (Intrexon Corporation) Profile
7.2.2 Precigen (Intrexon Corporation) Main Business
7.2.3 Precigen (Intrexon Corporation) Digital Biology Products, Services and Solutions
7.2.4 Precigen (Intrexon Corporation) Digital Biology Revenue (US$ Million) & (2019-2024)
7.2.5 Precigen (Intrexon Corporation) Recent Developments
7.3 Dassault Systèmes
7.3.1 Dassault Systèmes Profile
7.3.2 Dassault Systèmes Main Business
7.3.3 Dassault Systèmes Digital Biology Products, Services and Solutions
7.3.4 Dassault Systèmes Digital Biology Revenue (US$ Million) & (2019-2024)
7.3.5 Genedata AG Recent Developments
7.4 Genedata AG
7.4.1 Genedata AG Profile
7.4.2 Genedata AG Main Business
7.4.3 Genedata AG Digital Biology Products, Services and Solutions
7.4.4 Genedata AG Digital Biology Revenue (US$ Million) & (2019-2024)
7.4.5 Genedata AG Recent Developments
7.5 Simulations Plus, Inc.
7.5.1 Simulations Plus, Inc. Profile
7.5.2 Simulations Plus, Inc. Main Business
7.5.3 Simulations Plus, Inc. Digital Biology Products, Services and Solutions
7.5.4 Simulations Plus, Inc. Digital Biology Revenue (US$ Million) & (2019-2024)
7.5.5 Simulations Plus, Inc. Recent Developments
8 Industry Chain Analysis
8.1 Digital Biology Industrial Chain
8.2 Digital Biology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Digital Biology Sales Model
8.5.2 Sales Channel
8.5.3 Digital Biology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
DUNA Bioinformatics
Precigen (Intrexon Corporation)
Dassault Systèmes
Genedata AG
Simulations Plus, Inc.
Ìý
Ìý
*If Applicable.
